Thank you, Mr. Chair.
Thank you, Dr. Krkosek, for coming today and providing your testimony.
I have a number of questions that I'll throw out at once. If there's time, I may have a follow-up question. You seem quite confident that there is definitely a problem with sea lice affecting wild salmon, whereas we've heard previously at this committee and from other scientists that the evidence is inconclusive, or that it's hard to say, or that there are two camps at opposite ends of the spectrum that essentially don't agree with your conclusion.
So that's my first question: how are you so certain about the conclusion you're drawing?
Second, I'm wondering if you could comment on the tolerance of Slice on the west coast. There's been comment to this committee that there is not a problem in British Columbia. Could you confirm that this is the case, in your opinion? Also, if you happen to know how testing occurs for drug tolerance, could you comment on that, as well as on who does the testing, if you know, and how often those results are reported or published?
Finally, as you recommended management solutions, could you finish by commenting on what your top priorities would be for this industry, if there were, for instance, a recognized conclusion that sea lice are affecting wild salmon and an agreement that sea lice needed to be addressed? What would be the first things that should be addressed?